Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin for Muscle Cramps in Diabetic Neuropathy
NCT03238898Phase 2Completed
- Sponsor
- Garibaldi-Centro Hospital
- Start
- Sep 2014
- Primary completion
- May 2017
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 2, randomised, double-blind trial of botulinum toxin type A in muscle cramps (2 arms), sponsored by Garibaldi-Centro Hospital. Primary endpoint: Pain intensity on a 0-10 severity scale at 20 weeks. Started Sep 2014; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
muscle cramps
Beyond the preview
Go deeper on NCT03238898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03238898.